International Value Advisers LLC bought a new stake in Davita Inc (NYSE:DVA) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 625,266 shares of the company’s stock, valued at approximately $45,175,000. Davita comprises 1.3% of International Value Advisers LLC’s investment portfolio, making the stock its 22nd biggest position. International Value Advisers LLC owned 0.34% of Davita at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in the business. Ellington Management Group LLC purchased a new position in shares of Davita in the 4th quarter valued at approximately $1,077,000. HPM Partners LLC grew its stake in shares of Davita by 5.5% in the 4th quarter. HPM Partners LLC now owns 26,075 shares of the company’s stock valued at $1,884,000 after purchasing an additional 1,364 shares during the last quarter. Stone Ridge Asset Management LLC purchased a new position in shares of Davita in the 4th quarter valued at approximately $1,280,000. Deutsche Bank AG lifted its holdings in shares of Davita by 116.8% in the 4th quarter. Deutsche Bank AG now owns 406,542 shares of the company’s stock valued at $29,369,000 after buying an additional 219,055 shares during the period. Finally, Nomura Asset Management Co. Ltd. lifted its holdings in shares of Davita by 8.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 24,240 shares of the company’s stock valued at $1,751,000 after buying an additional 1,860 shares during the period. Institutional investors own 85.83% of the company’s stock.
Several research firms have recently commented on DVA. SunTrust Banks reissued a “hold” rating and issued a $80.00 price target on shares of Davita in a report on Wednesday, February 14th. Robert W. Baird set a $97.00 price target on Davita and gave the company a “buy” rating in a report on Tuesday, February 13th. Bank of America reissued a “buy” rating and issued a $92.00 price target (up from $85.00) on shares of Davita in a report on Thursday, January 11th. Zacks Investment Research raised Davita from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 2nd. Finally, TheStreet raised Davita from a “c” rating to a “b-” rating in a report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Davita currently has a consensus rating of “Hold” and a consensus target price of $79.30.
Davita Inc (NYSE DVA) opened at $72.46 on Monday. The stock has a market capitalization of $13,187.72, a price-to-earnings ratio of 21.06, a P/E/G ratio of 1.39 and a beta of 1.03. Davita Inc has a 1-year low of $52.51 and a 1-year high of $80.71. The company has a current ratio of 2.88, a quick ratio of 2.82 and a debt-to-equity ratio of 1.87.
Davita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.02). The firm had revenue of $2.78 billion for the quarter, compared to analyst estimates of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same period in the prior year, the firm posted $0.98 earnings per share. analysts predict that Davita Inc will post 4.15 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/03/12/international-value-advisers-llc-takes-45-18-million-position-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.